U.S. markets close in 2 hours 49 minutes
  • S&P 500

    4,410.30
    +42.82 (+0.98%)
     
  • Dow 30

    35,059.92
    +236.57 (+0.68%)
     
  • Nasdaq

    14,821.98
    +137.38 (+0.94%)
     
  • Russell 2000

    2,200.09
    +0.61 (+0.03%)
     
  • Crude Oil

    71.94
    +0.03 (+0.04%)
     
  • Gold

    1,802.60
    -2.80 (-0.16%)
     
  • Silver

    25.28
    -0.10 (-0.38%)
     
  • EUR/USD

    1.1774
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.2850
    +0.0200 (+1.58%)
     
  • GBP/USD

    1.3761
    -0.0007 (-0.05%)
     
  • USD/JPY

    110.5290
    +0.4140 (+0.38%)
     
  • BTC-USD

    32,131.97
    -272.65 (-0.84%)
     
  • CMC Crypto 200

    776.33
    -17.40 (-2.19%)
     
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

Why This High Dividend REIT Could Be A Steal Right Now

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

With interest rates still historically low, many investors are turning to high-yield real estate investment trusts as a reliable source of income. Yet a REIT’s dividend yield is only as reliable as its underlying business.

Sabra Health Care REIT Stock: One high-yield REIT that may be attractive to investors at current levels is Sabra Health Care REIT Inc (NASDAQ: SBRA). Sabra invests in health care real estate, including skilled nursing facilities, senior housing communities and specialty hospitals.

Related Link: 3 REITs To Buy With 10% Dividends

REITs are required by law to distribute 90% of taxable income to shareholders, and Sabra has a sizable 6.7% yield. In addition, shares are relatively undervalued based on the company’s funds from operations. FFO is simply the term REITs use to describe cash flow from operations.

Sabra Health Care REIT's Numbers: Sabra shares currently trade at a price-to-FFO ratio of around 10.5x, a significant discount to the average P/FFO average of the senior housing REIT group as a whole.

Sabra’s FFO peaked back in 2018, but it remains up 182.9% overall in the past five years.

Value investors likely love the REIT’s yield and attractive valuation, while skeptics likely point out that revenue, net income and FFO growth were all negative in 2019 prior to the pandemic.

After peaking at $22.08 in late 2019 prior to the emergence of the coronavirus, Sabra shares have now recovered nicely from a bottom of $5.11 in March 2020.

Sabra Health Care REIT's Outlook: Looking ahead, analysts are expecting Sabra shares to take a breather over the next 12 months. The average price target among the 14 analysts covering the stock is $18, suggesting just 1.4% upside.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.